Success rate 94.6% Of members in active treatment, 94.6% reach a measurable improvement milestone while staying engaged in care
Meera Shah, an endocrinologist at the Mayo Clinic, said that by far the most common side effect she sees in patients is nausea, followed by abdominal pain, constipation and diarrhea
Despite GLP-1 concentration being higher in the fundus than the antrum, its release ex vivo upon IBMX stimulation increases to the same extent in both the fundus and antrum, suggesting a significant contribution to both portal and gastric GLP-1 (Ribeiro-Parenti et al., 2021)
What is known is that IGF-1 is a growth signal, that some cancers respond to growth signals, and that women with a personal history of breast cancer, ovarian cancer, or any active malignancy are not candidates for growth hormone secretagogues regardless of how mild the protocol appears